Hims & Hers Health is trading at €27.24, up 4.45%, with no clear catalyst identified. - Hers launched in Australia on October 12, expanding its women’s-health services; no source directly links the announcement to the price move. - U.S. indexes were nearly flat on October 12, so broader-market gains do not clearly explain the move. - Available reporting says U.S.-listed shares fell 0.91% on October 12, underscoring differences by listing and timing.